TickerFactsScreenerDevelopers

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $02010: $02011: $31.1K2012: $02013: $13.0K2014: $1.59M2015: $1.14M2016: $1.52M2017: $1.03M2018: $1.20M2019: $6.92M2020: $46.79M2021: $37.57M2022: $20.43M2023: $22.29M2024: $11.07M2025: $33.84M$33.84M
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$33.84M+205.7%
2024$11.07M-50.3%
2023$22.29M+9.1%
2022$20.43M-45.6%
2021$37.57M-19.7%
2020$46.79M+576.5%
2019$6.92M+477.4%
2018$1.20M+16.5%
2017$1.03M-32.4%
2016$1.52M+33.1%
2015$1.14M-28.2%
2014$1.59M+12146.2%
2013$13.0K—
2012$0-100.0%
2011$31.1K—
2010$0—
2009$0—